Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Comprehensive Immunogenetic Analysis of Long COVID Reveals HLA-B*15 as an Independent Protective Factor.

Created on 13 Nov 2026

Authors

José Luis Cano-Perales, Pedro José Ortuño Pastor, Antonio Rosales-Castillo, Mónica Bernal, Jose Ramón Vilchez, Pilar Jimenez, Ana Marín-Sánchez, Antonio Rodriguez-Nicolas, Asier Lizama-Muñoz, Lucia Ballesta, Juan Sainz, Francisco Ruiz-Cabello, Miguel Angel López-Nevot, Juan Francisco Gutiérrez-Bautista

Published in

HLA. Volume 108. Issue 5.

Abstract

Long COVID is a frequent complication of SARS-CoV-2 infection, but the contribution of host immunogenetic factors to its development remains poorly understood. We investigated the association of HLA polymorphisms and other immunogenetic markers with Long COVID in a Spanish cohort. We performed a case-control study including 453 hospitalised patients with confirmed SARS-CoV-2 infection, of whom 168 developed Long COVID and 959 healthy controls. High-resolution HLA typing was performed together with analyses of conserved extended haplotypes (CEHs), HLA-B Bw4/Bw6 epitopes, HLA-C C1/C2 ligand groups, MICA short tandem repeat polymorphisms and the CCR5 Δ32 variant. Logistic regression was used to identify independent predictors of Long COVID. After correction for multiple testing, no high-resolution HLA allele remained significantly associated with Long COVID. However, the low-resolution HLA-B*15 serotype was significantly less frequent in patients with Long COVID and remained independently associated with a reduced risk of persistent symptoms after adjustment for age, sex and intensive care unit admission. The conserved extended haplotype CEH 44.2 was also less frequent among patients with Long COVID, although this association was not retained after multivariable adjustment. No significant associations were observed for HLA-B Bw4/Bw6 epitopes, HLA-C C1/C2 ligand groups, MICA polymorphisms or the CCR5 Δ32 variant. Our findings identify HLA-B*15 as an independent protective immunogenetic factor against Long COVID and support a role for HLA-mediated antiviral immunity in modulating susceptibility to persistent post-COVID manifestations. These results warrant validation in larger, independent cohorts.

PMID:
43023789
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement